A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate

NCT00243412 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: folate
DRUG: methotrexate
DRUG: methylprednisolone
DRUG: Placebo
DRUG: Rituximab

Sponsor

Genentech, Inc.